1. Home
  2. CRGX vs OCFT Comparison

CRGX vs OCFT Comparison

Compare CRGX & OCFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRGX
  • OCFT
  • Stock Information
  • Founded
  • CRGX 2021
  • OCFT 2015
  • Country
  • CRGX United States
  • OCFT China
  • Employees
  • CRGX N/A
  • OCFT N/A
  • Industry
  • CRGX
  • OCFT Computer Software: Programming Data Processing
  • Sector
  • CRGX
  • OCFT Technology
  • Exchange
  • CRGX Nasdaq
  • OCFT Nasdaq
  • Market Cap
  • CRGX 180.4M
  • OCFT 169.6M
  • IPO Year
  • CRGX 2023
  • OCFT 2019
  • Fundamental
  • Price
  • CRGX $4.64
  • OCFT $6.07
  • Analyst Decision
  • CRGX Hold
  • OCFT
  • Analyst Count
  • CRGX 7
  • OCFT 0
  • Target Price
  • CRGX $4.67
  • OCFT N/A
  • AVG Volume (30 Days)
  • CRGX 653.7K
  • OCFT 77.6K
  • Earning Date
  • CRGX 05-13-2025
  • OCFT 05-20-2025
  • Dividend Yield
  • CRGX N/A
  • OCFT N/A
  • EPS Growth
  • CRGX N/A
  • OCFT N/A
  • EPS
  • CRGX N/A
  • OCFT N/A
  • Revenue
  • CRGX N/A
  • OCFT $307,997,287.00
  • Revenue This Year
  • CRGX $58.18
  • OCFT N/A
  • Revenue Next Year
  • CRGX N/A
  • OCFT $6.37
  • P/E Ratio
  • CRGX N/A
  • OCFT N/A
  • Revenue Growth
  • CRGX N/A
  • OCFT N/A
  • 52 Week Low
  • CRGX $3.00
  • OCFT $0.87
  • 52 Week High
  • CRGX $25.45
  • OCFT $6.90
  • Technical
  • Relative Strength Index (RSI)
  • CRGX 59.08
  • OCFT 49.29
  • Support Level
  • CRGX $3.58
  • OCFT $5.40
  • Resistance Level
  • CRGX $4.17
  • OCFT $6.45
  • Average True Range (ATR)
  • CRGX 0.26
  • OCFT 0.33
  • MACD
  • CRGX 0.12
  • OCFT -0.10
  • Stochastic Oscillator
  • CRGX 92.98
  • OCFT 47.86

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.

About OCFT OneConnect Financial Technology Co. Ltd.

OneConnect Financial Technology Co Ltd is a provider of technology platforms. Its platform provides cloud-native technology solutions that integrate financial services with market technology. The company offers technology applications and technology-enabled business services to financial institutions in China. Its technology solutions cover multiple verticals in the financial services industry, including banking, insurance and asset management, across the full scope of their businesses from sales and marketing and risk management to customer services and operations, as well as technology infrastructures such as data management and cloud services. The firm operates in two segments namely Technology Solutions which is the key revenue driver and Virtual Bank Business.

Share on Social Networks: